Insulin Resistance Suppresses Ghrelin — Even When Body Weight Is the Same
Among equally obese adults, insulin-resistant individuals had 39% lower ghrelin levels than insulin-sensitive controls, independent of body weight.
Quick Facts
What This Study Found
Among equally obese adults (BMI ~32), those who were insulin-resistant had significantly lower ghrelin levels (252 pg/ml) than insulin-sensitive individuals (412 pg/ml; P<0.001) — a 39% difference. This finding separates the effect of insulin resistance from obesity itself on ghrelin suppression.
Ghrelin correlated inversely with both insulin resistance (r = -0.64; P<0.001) and fasting insulin levels (r = -0.58; P<0.001). Multivariate analysis confirmed that both insulin resistance and high insulin levels independently predicted low ghrelin, suggesting that insulin resistance — not just being overweight — drives ghrelin suppression. This points to a metabolic feedback loop where insulin resistance further suppresses the hunger hormone, potentially disrupting normal appetite regulation.
Key Numbers
How They Did This
Researchers used steady-state plasma glucose concentrations (a gold-standard measure of insulin sensitivity) to identify 20 insulin-resistant and 20 insulin-sensitive obese individuals who were matched for BMI (~32 kg/m²). They measured fasting ghrelin and insulin levels and performed multivariate analysis to determine whether insulin resistance and hyperinsulinemia independently predicted ghrelin suppression after controlling for body weight.
Why This Research Matters
Ghrelin is the body's main hunger signal, and it's known to be lower in obese people. But this study showed that it's not just about being overweight — insulin resistance independently suppresses ghrelin even further. This has important implications for understanding why metabolically unhealthy obese individuals may have disrupted appetite signaling, and it suggests that the insulin-ghrelin connection could be a key piece of the obesity puzzle.
The Bigger Picture
This study contributed to an important shift in understanding obesity: it's not just how much fat you carry, but how your metabolism handles it. The insulin-ghrelin connection helps explain why some obese people develop metabolic syndrome and others don't, and why appetite regulation breaks down differently across individuals. It also raises the question of whether improving insulin sensitivity (through exercise, metformin, or other interventions) could restore normal ghrelin signaling and improve appetite regulation — a concept that connects to modern GLP-1 drug research.
What This Study Doesn't Tell Us
This is a cross-sectional observational study — it shows correlation, not causation. The sample is relatively small (40 participants). The study measured fasting ghrelin only, not the dynamic ghrelin response to meals. It cannot determine whether low ghrelin causes further metabolic dysfunction or is merely a consequence of insulin resistance.
Questions This Raises
- ?Does improving insulin sensitivity (through exercise, medication, or weight loss) restore normal ghrelin levels?
- ?Is the suppression of ghrelin in insulin-resistant individuals a cause or consequence of their metabolic dysfunction?
- ?Do GLP-1 drugs, which improve insulin sensitivity, also normalize ghrelin signaling?
Trust & Context
- Key Stat:
- 39% lower ghrelin Insulin-resistant obese adults had dramatically lower levels of the hunger hormone ghrelin (252 vs 412 pg/ml) compared to equally obese but insulin-sensitive adults.
- Evidence Grade:
- This is a well-designed human observational study with careful matching for BMI and gold-standard insulin sensitivity measurement. However, the small sample size (n=40) and cross-sectional design limit causal conclusions.
- Study Age:
- Published in 2004, this is an early and influential study in ghrelin metabolism research. The core findings have been supported by subsequent studies and remain relevant to current understanding of appetite hormone regulation.
- Original Title:
- Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.
- Published In:
- The Journal of clinical endocrinology and metabolism, 89(4), 1630-5 (2004)
- Database ID:
- RPEP-00948
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Why does insulin resistance lower ghrelin levels?
High insulin levels (which accompany insulin resistance) appear to directly suppress ghrelin production. This creates a paradox: insulin-resistant people have lower levels of the hunger hormone, yet they don't eat less — suggesting other appetite-regulating mechanisms are also disrupted.
Does this mean insulin-resistant people feel less hungry?
Not necessarily. While their ghrelin levels are lower, insulin resistance also disrupts other appetite signals like leptin and GLP-1. The overall effect is often increased appetite and difficulty feeling satisfied, despite the ghrelin suppression. The appetite system is complex and doesn't rely on a single hormone.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00948APA
McLaughlin, Tracey; Abbasi, Fahim; Lamendola, Cindy; Frayo, R Scott; Cummings, David E. (2004). Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.. The Journal of clinical endocrinology and metabolism, 89(4), 1630-5.
MLA
McLaughlin, Tracey, et al. "Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.." The Journal of clinical endocrinology and metabolism, 2004.
RethinkPeptides
RethinkPeptides Research Database. "Plasma ghrelin concentrations are decreased in insulin-resis..." RPEP-00948. Retrieved from https://rethinkpeptides.com/research/mclaughlin-2004-plasma-ghrelin-concentrations-are
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.